Paul M. Ossenkoppele

640 citations
14 papers · 447 · h-index 10

Impact in

  • Immunology top 10%
    • Psoriasis: Treatment and Pathogenesis
  • Microbiology top 5%
    • Reproductive tract infections research

Papers in

Co-authors
E.M.G.J. de Jong (11 shared papers)M.D. Njoo (9 shared papers)M.I.A. Koetsier (9 shared papers)Wietske Kievit (8 shared papers)J.M. Mommers (10 shared papers)Marisol E. Otero (9 shared papers)P.C.M. van de Kerkhof (8 shared papers)A.L.A. Kuijpers (6 shared papers)
Journals
British Journal of Dermatology (5 papers)Acta Dermato Venereologica (2 papers)Journal of Clinical Microbiology (1 paper)Journal of the European Academy of Dermatology and Venereology (1 paper)Journal of Dermatological Treatment (1 paper)
Partner nations
NetherlandsUnited States

In The Last Decade

Paul M. Ossenkoppele

11 papers receiving 439 citations

Peers

Paul M. Ossenkoppele
Comparison fields: 5 of 48
  • Immunology 307
  • Microbiology 82
  • Dermatology 84
  • Rheumatology 38
  • Pediatrics, Perinatology and Child Health 34
Replace Marcelo Arnone with:
Marcelo Arnone Brazil
A. Jurado Spain
Patricia Nell United States
Stephen Rowntree United Kingdom
Martin D. Keltz United States
Güzin Özarmağan Türkiye
C. James Sung United States
Abolhassan Farhoudi Iran
Engin Türkgeldi Türkiye
Andrea Kalus United States
Paul M. Ossenkoppele relative to Marcelo Arnone Brazil Marcelo Arnone's profile →
Citations per field
00.5×2×3×3.7×
Marcelo Arnone · 1×
Citations per year

Countries citing papers authored by Paul M. Ossenkoppele

Since Specialization
Citations

This map shows the geographic impact of Paul M. Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Ossenkoppele more than expected).

Fields of papers citing papers by Paul M. Ossenkoppele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Ossenkoppele. The network helps show where Paul M. Ossenkoppele may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul M. Ossenkoppele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul M. Ossenkoppele Line = papers co-authored together Paul M. Ossenkoppele links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis
Journal of Clinical Microbiology ·J M Ossewaarde, M. Rieffe, M. Rozenberg-Arska, Paul M. Ossenkoppele, R. P. Nawrocki, Anton M. van Loon
199289
2
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetwork
British Journal of Dermatology ·J. M. P. A. van den Reek, Jeffrey Zweegers, Wietske Kievit, Marisol E. Otero, P.P.M. van Lümig, R.J.B. Driessen, Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, B.A.M. Sybrandy‐Fleuren, A.L.A. Kuijpers, M.P.M. Andriessen, P.C.M. van de Kerkhof, Marieke M.B. Seyger, E.M.G.J. de Jong
201477
3
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
British Journal of Dermatology ·Jeffrey Zweegers, J.M.P.A. van den Reek, P.C.M. van de Kerkhof, Marisol E. Otero, A.L.A. Kuijpers, M.I.A. Koetsier, W.P. Arnold, M.A.M. Berends, Lizelotte J.M.T. Weppner‐Parren, Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, P.P.M. van Lümig, R.J.B. Driessen, Wietske Kievit, E.M.G.J. de Jong
201660
4
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
Acta Dermato Venereologica ·J.M.P.A. van den Reek, Lieke J. van Vugt, Martijn B. A. van Doorn, G. E. van der Kraaij, W.J. Kort, G.P.H. Lucker, Barbara Horváth, M.D. Njoo, H Bovenschen, Paul M. Ossenkoppele, Marjolein de Bruin‐Weller, M. de Groot, Roland J. M. Mommers, Ruud L.M.A. Prevoo, P.C.M. van de Kerkhof, Phyllis I. Spuls, Wietske Kievit, E.M.G.J. de Jong
201848
5
Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry
British Journal of Dermatology ·Jeffrey Zweegers, J.M.M. Groenewoud, J. M. P. A. van den Reek, Marisol E. Otero, P.C.M. van de Kerkhof, R.J.B. Driessen, P.P.M. van Lümig, M.D. Njoo, Paul M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, M.P.M. Andriessen, A.L.A. Kuijpers, M.A.M. Berends, Wietske Kievit, E.M.G.J. de Jong
201638
6
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis
JAMA Dermatology ·Selma Atalay, J.M.P.A. van den Reek, Alfons A den Broeder, Lieke J. van Vugt, Marisol E. Otero, M.D. Njoo, J.M. Mommers, Paul M. Ossenkoppele, M.I.A. Koetsier, M.A.M. Berends, P.C.M. van de Kerkhof, Hans Groenewoud, Wietske Kievit, E.M.G.J. de Jong
202036
7
Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry
Journal of the European Academy of Dermatology and Venereology ·L. S. van der Schoot, J.M.P.A. van den Reek, J.M.M. Groenewoud, Marisol E. Otero, M.D. Njoo, Paul M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, M.A.M. Berends, W.P. Arnold, B Peters, M.P.M. Andriessen, Clara Hengst, A.L.A. Kuijpers, E.M.G.J. de Jong
201934
8
Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network
British Journal of Dermatology ·J.M.P.A. van den Reek, P.P.M. van Lüumig, Marisol E. Otero, Jeffrey Zweegers, P.C.M. van de Kerkhof, Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, B.A.M. Sybrandy‐Fleuren, A.L.A. Kuijpers, M.P.M. Andriessen, Marieke M.B. Seyger, Wietske Kievit, E.M.G.J. de Jong
201425
9
Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: Bio CAPTURE
British Journal of Dermatology ·Jeffrey Zweegers, J. M. P. A. van den Reek, P. C. M. vande Kerkhof, Marisol E. Otero, Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, B.A.M. Sybrandy‐Fleuren, A.L.A. Kuijpers, M.P.M. Andriessen, Wietske Kievit, E.M.G.J. de Jong
201419
10
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
Acta Dermato Venereologica ·Selma Atalay, J.M.P.A. van den Reek, Marisol E. Otero, M.D. Njoo, J.M. Mommers, Paul M. Ossenkoppele, M.I.A. Koetsier, Maartje M Berends, P.C.M. van de Kerkhof, Hans Groenewoud, Alfons A den Broeder, E.M.G.J. de Jong, Wietske Kievit
202012
11
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
Journal of Dermatological Treatment ·Selma Atalay, Sophie E. Berends, Hans Groenewoud, Ron A. A. Mathôt, David Njoo, J.M. Mommers, Paul M. Ossenkoppele, M.I.A. Koetsier, M.A.M. Berends, Annick de Vries, P.C.M. van de Kerkhof, Alfons A den Broeder, E.M.G.J. de Jong, J. M. P. A. van den Reek
20229
12
A Case of Hypercalcemia in an Immunocompetent Patient with Disseminated Mycobacterium marinum Infection with a Rain Barrel as the Most Likely Primary Source
European Journal of Case Reports in Internal Medicine ·Wendy Uijtendaal, Rima Yohanna, Folkert W. Visser, Paul M. Ossenkoppele, Dorine Hess, Dennis Boumans
20210
13
[Granuloma annulare after herpes zoster: Wolf's isotopic response].
PubMed ·R Rademaker, E van Dalen, Paul M. Ossenkoppele, G J Knuiman, S M Kemme
20210
14
Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasis
Clinical and Experimental Dermatology ·Nikki F T Henckens, Marisol E. Otero, J. M. P. A. van den Reek, E.M.G.J. de Jong, (unknown), R.R.M.C. Keijsers, P.P.M. van Lümig, Paul M. Ossenkoppele, Inge Haeck, (unknown), (unknown), Sharon R. P. Dodemont, Berit Velstra, Femke M. Homan, (unknown), Robert Jan Lindhout, A.M. Oostveen, Bas Peters, J.M. Mommers, Martijn B. A. van Doorn, Milan Tjioe, W.P. Arnold, (unknown), Marloes M. Kleinpenning
20240

About Paul M. Ossenkoppele

Paul M. Ossenkoppele is a scholar working on Immunology, Dermatology, Epidemiology, Infectious Diseases and Small Animals, having authored 14 papers that have together received 447 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (11 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Tuberculosis Research and Epidemiology (1 paper), Infectious Diseases and Mycology (1 paper), Mycobacterium research and diagnosis (1 paper), Reproductive tract infections research (1 paper), Urinary Tract Infections Management (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Immunology (307 citations), Microbiology (82 citations), Dermatology (84 citations), Rheumatology (38 citations) and Pediatrics, Perinatology and Child Health (34 citations). Paul M. Ossenkoppele has collaborated with scholars based in Netherlands and United States. Frequent co-authors include E.M.G.J. de Jong, M.D. Njoo, M.I.A. Koetsier, Wietske Kievit, J.M. Mommers, Marisol E. Otero, P.C.M. van de Kerkhof, A.L.A. Kuijpers, W.P. Arnold and Anton M. van Loon. Their work appears in journals such as British Journal of Dermatology, Acta Dermato Venereologica, Journal of Clinical Microbiology, Journal of the European Academy of Dermatology and Venereology and Journal of Dermatological Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcelo ArnoneBreakdown of academic impact, for papers by A. JuradoBreakdown of academic impact, for papers by Patricia NellBreakdown of academic impact, for papers by Stephen RowntreeBreakdown of academic impact, for papers by Martin D. KeltzBreakdown of academic impact, for papers by Güzin ÖzarmağanBreakdown of academic impact, for papers by C. James SungBreakdown of academic impact, for papers by Abolhassan FarhoudiBreakdown of academic impact, for papers by Engin TürkgeldiBreakdown of academic impact, for papers by Andrea Kalus